whose hypotensive effect is related to dose and extent of blood pressure increase, can be administered once daily(usual maintenance dose is 10-40 mg/d), it most often is given twice daily to blunt a significant increase in heart rate that may accompany peak plasma concentrations of the drug. The tachycardia and fluid retention that accompanies mi noxidil therapy is even more striking than that observed with hydralazine therapy. Edema and weight gain can be rapid
and profound, often necessitating high doses of loop diuretics. Empirically, it has been observed that the addition of metolazone to the loop diuretic may augment the natriuretic response more than further increasing the loop diuretic dose.